… Background COVID-19vaccines approved in the UK are highly effective in general … estimate vaccine antibody response and vaccine effectiveness against medically attended COVID-19 …
L Lebedev, M Sapojnikov, A Wechsler… - American Journal of …, 2021 - Elsevier
… side effect of the COVID-19vaccination, our case report … conclusively attributed to the COVID-19vaccine. Of significance is … to weeks following COVID-19vaccination should undergo a …
AI Francis, S Ghany, T Gilkes… - Postgraduate medical …, 2022 - academic.oup.com
… effects of Covid-19. This study aims to discuss the most recent WHO-approved Covid-19 vaccine subtypes, their … The vaccines discussed in this study are Pfizer/BNT162b2, Moderna …
SA Meo, IA Bukhari, J Akram, AS Meo… - European Review for …, 2021 - europeanreview.org
… pandemic (COVID-19), with huge … Pfizer/ BioNTech and Moderna COVID-19vaccines. Many people have a history of a significant allergic reaction to a specific food, medicine, or vaccine…
DE McMahon, E Amerson, M Rosenbach… - Journal of the American …, 2021 - Elsevier
… COVID-19vaccines. We observed some dermatologic reactions to Moderna and Pfizervaccines … Our data support that cutaneous reactions to COVID-19vaccination are generally minor …
S Waheed, A Bayas, F Hindi, Z Rizvi, PS Espinosa - Cureus, 2021 - ncbi.nlm.nih.gov
… reported case of GBS after receiving the first dose of PfizerCOVID-19vaccine. … COVID-19 post vaccine associated GBS. In this pandemic and with ongoing worldwide mass vaccination …
… In a report from the national Vaccine Adverse Event Reporting System, … the Pfizer-BioNTech COVID-19vaccine, of whom 44 were women (94%). For the Moderna COVID-19vaccine, 19 …
E Tano, S San Martin, S Girgis… - Journal of the …, 2021 - academic.oup.com
… This case series raises additional questions regarding appropriate recommendations for COVID-19vaccination in adolescents with a prior history of perimyocarditis, of SARS CoV-2 …
SJ Rao, S Khurana, G Murthy, ET Dawson… - Journal of community …, 2021 - Taylor & Francis
… the second dose of the PfizerCOVID-19vaccine, in a 42-… COVID-19vaccines remains limited, and prompt recognition of potential neurological complications from the COVID-19vaccine …